Cargando…
On the Use of Local Assessments for Monitoring Centrally Reviewed Endpoints with Missing Data in Clinical Trials()
Due to ethical and logistical concerns it is common for data monitoring committees to periodically monitor accruing clinical trial data to assess the safety, and possibly efficacy, of a new experimental treatment. When formalized, monitoring is typically implemented using group sequential methods. I...
Autores principales: | Brummel, Sean S., Gillen, Daniel L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4273501/ https://www.ncbi.nlm.nih.gov/pubmed/25540717 http://dx.doi.org/10.4236/ojs.2013.34A005 |
Ejemplares similares
-
Missing tumor measurement (TM) data in the search for alternative TM-based endpoints in cancer clinical trials
por: An, Ming-Wen, et al.
Publicado: (2019) -
Blinded continuous monitoring in clinical trials with recurrent event endpoints
por: Friede, Tim, et al.
Publicado: (2018) -
Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT study
por: Mahaffey, Kenneth W, et al.
Publicado: (2001) -
Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series
por: McDonald, James, et al.
Publicado: (2023) -
IPF clinical trial design and endpoints
por: Nathan, Steven D., et al.
Publicado: (2014)